Blood markers for healing after a heart attack
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study is looking at certain blood markers and heart tissue changes in people who have recently had a heart attack. The goal is to understand how the heart heals and remodels after an attack, which could help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with a heart attack, confirmed by symptoms, blood tests (troponin), ECG, and an angiogram showing a blocked or narrowed heart artery.
- You must not have had prior heart surgery such as bypass grafting or percutaneous coronary intervention (like stenting).
- You must not have other serious heart conditions like heart failure, congenital heart defects, or cardiomyopathy.
- You must not have serious medical problems such as cancer, severe infections, organ failure, autoimmune diseases, or be pregnant.
- You must be willing and able to fully cooperate with the study process.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study uses advanced CT scans and blood tests to look at how the heart is damaged and recovers after a first heart attack. It may help doctors find better ways to treat heart attacks in the future.
This study looks at how aging affects recovery in people who have had a heart attack at least 3 months ago. It may help doctors better understand and care for older heart patients.
This trial is testing a new way to quickly measure the level of a blood thinner (tirofiban) in the blood of people having a heart attack. It aims to make sure the dose is right and safe for each patient.
This study uses advanced CT scans to take detailed pictures of your heart and blood vessels after a recent heart attack treated with stent placement. The goal is to better understand heart damage and predict long-term outcomes.
This study looks at whether certain blood markers (related to inflammation and heart damage) can help tell how well your heart is working after a heart attack. By joining, you could help doctors better predict heart function problems and improve care for future patients.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.